Edgestream Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $428K | Buy |
+3,765
| New | +$428K | 0.01% | 752 |
|
|
2024
Q4 | – | Sell |
-34,069
| Closed | -$3.41M | – | 989 |
|
|
2024
Q3 | $3.41M | Buy |
+34,069
| New | +$3.41M | 0.15% | 227 |
|
|
2022
Q2 | – | Sell |
-28,402
| Closed | -$1.99M | – | 578 |
|
|
2022
Q1 | $1.99M | Sell |
28,402
-14,073
| -33% | -$988K | 0.16% | 214 |
|
|
2021
Q4 | $4.09M | Sell |
42,475
-11,129
| -21% | -$1.07M | 0.26% | 119 |
|
|
2021
Q3 | $4.66M | Sell |
53,604
-14,969
| -22% | -$1.3M | 0.29% | 114 |
|
|
2021
Q2 | $5.61M | Buy |
+68,573
| New | +$5.61M | 0.33% | 101 |
|